130 related articles for article (PubMed ID: 26106521)
21. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
22. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
[TBL] [Abstract][Full Text] [Related]
23. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
[TBL] [Abstract][Full Text] [Related]
24. microRNA-148a inhibits hepatocellular carcinoma cell invasion by targeting sphingosine-1-phosphate receptor 1.
Zhang SL; Liu L
Exp Ther Med; 2015 Feb; 9(2):579-584. PubMed ID: 25574238
[TBL] [Abstract][Full Text] [Related]
25. Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells.
Neel JC; Lebrun JJ
Cell Signal; 2013 Jul; 25(7):1556-66. PubMed ID: 23524334
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset.
Boo L; Ho WY; Mohd Ali N; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Cheong SK; Ong HK
PeerJ; 2017; 5():e3551. PubMed ID: 28717596
[TBL] [Abstract][Full Text] [Related]
27. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells.
Gailhouste L; Gomez-Santos L; Hagiwara K; Hatada I; Kitagawa N; Kawaharada K; Thirion M; Kosaka N; Takahashi RU; Shibata T; Miyajima A; Ochiya T
Hepatology; 2013 Sep; 58(3):1153-65. PubMed ID: 23532995
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT
Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743
[TBL] [Abstract][Full Text] [Related]
29. Participation of an abnormality in the transforming growth factor-beta signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor.
Zhang L; Sato E; Amagasaki K; Nakao A; Naganuma H
J Neurosurg; 2006 Jul; 105(1):119-28. PubMed ID: 16871886
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
31. The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy.
Zhan Q; Fang Y; Deng X; Chen H; Jin J; Lu X; Peng C; Li H; Shen B
Cancer Invest; 2015; 33(7):267-75. PubMed ID: 25950085
[TBL] [Abstract][Full Text] [Related]
32. MiR-148a inhibits angiogenesis by targeting ERBB3.
Yu J; Li Q; Xu Q; Liu L; Jiang B
J Biomed Res; 2011 May; 25(3):170-7. PubMed ID: 23554686
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.
Wang X; Jiang F; Mu J; Ye X; Si L; Ning S; Li Z; Li Y
Toxicol Lett; 2014 Jun; 227(2):75-83. PubMed ID: 24680928
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.
Pan L; Huang S; He R; Rong M; Dang Y; Chen G
Eur J Med Res; 2014 Dec; 19(1):68. PubMed ID: 25444499
[TBL] [Abstract][Full Text] [Related]
35. MiR-148a impairs Ras/ERK signaling in B lymphocytes by targeting SOS proteins.
Alles J; Ludwig N; Rheinheimer S; Leidinger P; Grässer FA; Keller A; Meese E
Oncotarget; 2017 Aug; 8(34):56417-56427. PubMed ID: 28915601
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-148a: a potential therapeutic target for cancer.
Chen Z; Ma T; Huang C; Zhang L; Xu T; Hu T; Li J
Gene; 2014 Jan; 533(1):456-7. PubMed ID: 24084367
[TBL] [Abstract][Full Text] [Related]
37. MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells.
Li L; Shi JY; Zhu GQ; Shi B
J Cell Biochem; 2012 Apr; 113(4):1235-44. PubMed ID: 22095742
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-128 suppresses paclitaxel-resistant lung cancer by inhibiting MUC1-C and BMI-1 in cancer stem cells.
Koh H; Park H; Chandimali N; Huynh DL; Zhang JJ; Ghosh M; Gera M; Kim N; Bak Y; Yoon DY; Park YH; Kwon T; Jeong DK
Oncotarget; 2017 Dec; 8(66):110540-110551. PubMed ID: 29299167
[TBL] [Abstract][Full Text] [Related]
39. HK2 Is a Crucial Downstream Regulator of miR-148a for the Maintenance of Sphere-Forming Property and Cisplatin Resistance in Cervical Cancer Cells.
Yang H; Hou H; Zhao H; Yu T; Hu Y; Hu Y; Guo J
Front Oncol; 2021; 11():794015. PubMed ID: 34858863
[TBL] [Abstract][Full Text] [Related]
40. Expression of Concern: Upregulation of microRNA-148a inhibits proliferation, invasion and migration while promoting apoptosis of cervical cancer cells by downregulating RRS1.
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32584393
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
